Notice of Intent to Sole Source: JLS Research to obtain Hyline Fertile Chicken Eggs.

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price ID/IQ to JLS Reseach to obtain Hyline Fertile Chicken Eggs. Embryonated chicken eggs are used singularly and in conjunction with various tissue culture systems for the isolation of influenza viruses. The embryonated chicken eggs provide a relatively inexpensive and reliable way to produce large quantities of candidate vaccine viruses, for storage of seed viruses, and for the shipment of working quantities of viruses to test antibody responses to various influenza proteins. Deliveries shall be made on a weekly basis, in quantities to be determined by the Project Officer as each option is exercised and will remain consistent unless otherwise specified by the Project Officer. A minimum of 250 dozen highest quality grade Hyline fertile chicken eggs and a maximum of 540 dozen highest quality grade Hyline fertile chicken eggs shall be delivered in any one-week delivery period. Fertile chicken eggs shall be ordered by delivery orders. The quantity, amount and delivery scheduled will be stated on each individual delivery order with a 2-4 week notice for increases and/or decreases of total dozen per week delivery.

The National Center for Immunization and Respiratory Diseases (NCIRD), Influenza Division (ID) has used Hyline fertile chicken eggs for vaccine seed preparation and influenza research for several years. During this time, the maintenance of quality and consistency in the supply of Hyline eggs has remained crucial in the success of ID programs. Continuing to maintain consistency in the Hyline eggs supplied is recommended for program success. The contract will specify a period of performance for one year and contain four one-year option periods, to continue contractor performance up to a total of five years. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1(b) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at Qrz9@cdc.gov by 12:00 pm 15 August, 2023.